With age, especially in patients with AD, a dramatic increase in Arg3.1/Arc interactions with filamin A (FLNA), instead of PSD95, is observed, resulting in a dominant presence of Arg3.1/Arc in FLNA signaling complexes, a critical scaffold protein, modulating a variety of receptors and signaling molecules. The gene discussed is ARC; the disease is Alzheimer disease.